Researcher Profile

Keywords Cloud

KRIBB Co-Working

Results 1-20 of 102 (Search time: 0.006 seconds).

No. Year Title Type
102 2024

2024Article

Contribution of HSP90 cleavage to the cytotoxic effect of suberoylanilide hydroxamic acid in vivo and the involvement of TXNIP in HSP90 cleavageBiomolecules & Therapeutics, vol. 32, no. 1, pp. 115-122S Park; D Kim; Haiyoung Jung; In Pyo Choi; H J Kwon; Y Lee
Article
101 2024

2024Article

PLK1 phosphorylates RhoGDI1 and promotes cancer cell migration and invasionCancer Cell International, vol. 24, pp. 73-73Jeewon Lim; Yo Sep Hwang; Hyang Ran Yoon; J Yoo; Suk Ran YoonHaiyoung JungHee Jun ChoHee Gu Lee
Article
100 2024

2024Article

Deficiency of thioredoxin-interacting protein (TXNIP) results in age-related thrombocytopenia due to megakaryocyte oxidative stressJournal of Thrombosis and Haemostasis, vol. 22, no. 3, pp. 834-850Eunju Shin; C Park; Taeho Park; Hyunmin Chung; H Hwang; Sung Ho Bak; Kyung-Sook ChungSuk Ran YoonTae-Don Kim; In Pyo Choi, et al.
Article
99 2024

2024Article

Cisplatin induces kidney cell death via ROS-dependent MAPK signaling pathways by targeting peroxiredoxin I and II in African Green Monkey (Chlorocebus aethiops sabaeus) kidney cellsin Vivo, vol. 38, no. 2, pp. 630-639H N Zhang; W Q Xiao; D H Lee; N Li; Y Y Feng; T Su; H Y Gu; Ijoo Yoon; Haiyoung JungKyung Ho Lee, et al.
Article
98 2024

2024Article

Txnip regulates the Oct4-mediated pluripotency circuitry via metabolic changes upon differentiationCellular and Molecular Life Sciences, vol. 18, pp. 142-142SoJung Kwak; Cho Lok Song; Yee Sook Cho; In Pyo Choi; Jae Eun Byun; Haiyoung JungJungwoon Lee
Article
97 2023

2023Article

NgR1 is an NK cell inhibitory receptor that destabilizes the immunological synapseNature Immunology, vol. 24, no. 3, pp. 463-473Se-Chan Oh; S E Kim; In Hwan Jang; Seok-Min Kim; Soo Yun Lee; Sunyoung Lee; In-Sun Chu; Suk Ran YoonHaiyoung Jung; In Pyo Choi, et al.
Article
96 2023

2023Research Project

In silico 기반 조혈줄기세포 역노화 기술 개발연구책임자 : 정해용 / 사업기간 : 2023.05.01 ~ 2024.04.30
Research Project
95 2023

2023Research Project

조혈줄기세포 운명결정 인자 WIP1의 NK 세포 분화 및 활성 조절 연구 = Regulation of natural killer cell development and cytotoxicity by hematopoietic stem cell fate determining factor WIP1연구책임자 : 정해용 / 사업기간 : 2023.03.01 ~ 2024.02.29
Research Project
94 2023

2023Research Project

항암 면역세포 치료기술 개발 = Developemnt of anti-cancer immunotherapy연구책임자 : 윤석란 / 사업기간 : 2023.01.01 ~ 2023.12.31
Research Project
93 2023

2023Article

Understanding NK cell biology for harnessing NK cell therapies: targeting cancer and beyondFrontiers in Immunology, vol. 14, pp. 1192907-1192907Eunju Shin; Seong Ho Bak; Taeho Park; Jin Woo Kim; Suk Ran YoonHaiyoung JungJi Yoon Noh
Article
92 2023

2023Article

IL-17A and Th17 cells contribute to endometrial cell survival by inhibiting apoptosis and NK cell mediated cytotoxicity of endometrial cells via ERK1/2 pathwayImmune Network, vol. 23, no. 2, pp. e14-e14Young-Ju Kang; Hee Jun Cho; Yunhee Lee; Arum Park; Mi Jeong Kim; I C Jeung; Y W Jung; Haiyoung Jung; In Pyo Choi; Hee Gu Lee, et al.
Article
91 2023

2023Research Project

단백질 분해 기반 신약개발 플랫폼 기술 개발 = Development of drug discovery platform based on targeted protein degradation연구책임자 : 김정훈 / 사업기간 : 2023.01.01 ~ 2023.12.31
Research Project
90 2023

2023Article

Natural killer cells and immunotherapyInternational Journal of Molecular Sciences, vol. 24, no. 10, pp. 8760-8760Ji Yoon NohHaiyoung Jung
Article
89 2023

2023Article

The infusion of ex vivo, interleukin-15 and -21-activated donor NK cells after haploidentical HCT in high-risk AML and MDS patients-a randomized trialLeukemia, vol. 37, pp. 807-819K H Lee; Suk Ran Yoon; J R Gong; E J Choi; H S Kim; C J Park; S C Yun; Soo-Yeon Park; Sol Ji Jung; Hanna Kim, et al.
Article
88 2023

2023Research Project

세포기반 인공혈액의 세포 및 비임상 평가 모델 구축연구책임자 : 정해용 / 사업기간 : 2023.07.01 ~ 2024.03.31
Research Project
87 2022

2022Patent

아커만시아 뮤시니필라 균주 또는 이의 배양물을 유효성분으로 함유하는 노화방지용 조성물KR10-2022-0004861 (2022.01.12) / 10-2467815 (2022.11.11)김경심정해용황정환; 김병찬; 김용훈; 김재훈; 노정란장동호최영근이철호, et al.
Patent
86 2022

2022Patent

아커만시아 뮤시니필라 균주 또는 이의 배양물을 유효성분으로 함유하는 노화방지용 조성물KR10-2019-0114826 (2019.09.18) / 10-2377407 (2022.03.17)김경심정해용황정환; 김병찬; 김용훈; 김재훈; 노정란장동호최영근이철호, et al.
Patent
85 2022

2022Article

Synaptotagmin 11 scaffolds MKK7-JNK signaling process to promote stem-like molecular subtype gastric cancer oncogenesisJournal of Experimental & Clinical Cancer Research, vol. 41, pp. 212-212Bo Kyung Kim; Da Mi Kim; Hyunkyung Park; Seon-Kyu Kim; Mi Aie Hwang; Jungwoon LeeMi-Jung Kang; Jae Eun Byun; Joo-Young ImMinho Kang, et al.
Article
84 2022

2022Article

Ginsenoside 20(R)-Rg3 enhances natural killer cell activity by increasing activating receptor expression through the MAPK/ERK signaling pathwayInternational Immunopharmacology, vol. 107, pp. 108618-108618Yunhee Lee; Arum Park; Young-Jun ParkHaiyoung JungTae-Don KimJi Yoon Noh; In Pyo Choi; S Lee; Suk Ran Yoon
Article
83 2022

2022Article

SARS-CoV-2 peptides bind to NKG2D and increase NK cell activityCellular Immunology, vol. 371, pp. 104454-104454Hanna Kim; Byun Jae Eun; Suk Ran Yoon; H Koohy; Haiyoung Jung; In Pyo Choi
Article
1 2 3 4 5 6